208 related articles for article (PubMed ID: 25376239)
1. Role of the MAPKs/TGF-β1/TRAF6 signaling pathway in atrial fibrosis of patients with chronic atrial fibrillation and rheumatic mitral valve disease.
Zhang D; Liu X; Chen X; Gu J; Li F; Zhang W; Zheng Y
Cardiology; 2014; 129(4):216-23. PubMed ID: 25376239
[TBL] [Abstract][Full Text] [Related]
2. Role of the MAPKs/TGF-β1/TRAF6 signaling pathway in postoperative atrial fibrillation.
Zhang D; Chen X; Wang Q; Wu S; Zheng Y; Liu X
PLoS One; 2017; 12(3):e0173759. PubMed ID: 28323847
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II increases CTGF expression via MAPKs/TGF-β1/TRAF6 pathway in atrial fibroblasts.
Gu J; Liu X; Wang QX; Tan HW; Guo M; Jiang WF; Zhou L
Exp Cell Res; 2012 Oct; 318(16):2105-15. PubMed ID: 22749815
[TBL] [Abstract][Full Text] [Related]
4. Calreticulin overexpression correlates with integrin-α5 and transforming growth factor-β1 expression in the atria of patients with rheumatic valvular disease and atrial fibrillation.
Zhao F; Zhang S; Shao Y; Wu Y; Qin J; Chen Y; Chen L; Gu H; Wang X; Huang C; Zhang W
Int J Cardiol; 2013 Oct; 168(3):2177-85. PubMed ID: 23465222
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of connective tissue growth factor and transforming growth factor-beta-1 in atrial myocardium of patients with chronic atrial fibrillation.
Li Y; Jian Z; Yang ZY; Chen L; Wang XF; Ma RY; Xiao YB
Cardiology; 2013; 124(4):233-40. PubMed ID: 23571482
[TBL] [Abstract][Full Text] [Related]
6. Increased α-Actinin-2 Expression in the Atrial Myocardium of Patients with Atrial Fibrillation Related to Rheumatic Heart Disease.
Zhang L; Zhang N; Tang X; Liu F; Luo S; Xiao H
Cardiology; 2016; 135(3):151-159. PubMed ID: 27344599
[TBL] [Abstract][Full Text] [Related]
7. TGF-beta1 expression and atrial myocardium fibrosis increase in atrial fibrillation secondary to rheumatic heart disease.
Xiao H; Lei H; Qin S; Ma K; Wang X
Clin Cardiol; 2010 Mar; 33(3):149-56. PubMed ID: 20235205
[TBL] [Abstract][Full Text] [Related]
8. TGFβ1 and HGF regulate CTGF expression in human atrial fibroblasts and are involved in atrial remodelling in patients with rheumatic heart disease.
Chen JQ; Guo YS; Chen Q; Cheng XL; Xiang GJ; Chen MY; Wu HL; Huang QL; Zhu PL; Zhang JC
J Cell Mol Med; 2019 Apr; 23(4):3032-3039. PubMed ID: 30697920
[TBL] [Abstract][Full Text] [Related]
9. Focal adhesion kinase mediates atrial fibrosis via the AKT/S6K signaling pathway in chronic atrial fibrillation patients with rheumatic mitral valve disease.
Zhang P; Wang W; Wang X; Wang X; Song Y; Zhang J; Zhao H
Int J Cardiol; 2013 Oct; 168(4):3200-7. PubMed ID: 23639457
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of pioglitazone on atrial structural and electrical remodeling in vitro cellular models.
Gu J; Liu X; Wang QX; Guo M; Liu F; Song ZP; Zhang DD
J Mol Cell Cardiol; 2013 Dec; 65():1-8. PubMed ID: 24100253
[TBL] [Abstract][Full Text] [Related]
11. TGF-β1 and TIMP-4 regulate atrial fibrosis in atrial fibrillation secondary to rheumatic heart disease.
Sun Y; Huang ZY; Wang ZH; Li CP; Meng XL; Zhang YJ; Su F; Ma N
Mol Cell Biochem; 2015 Aug; 406(1-2):131-8. PubMed ID: 25971370
[TBL] [Abstract][Full Text] [Related]
12. Atrial fibrillation in pure rheumatic mitral valvular disease is expression of an atrial histological change.
Alessandri N; Tufano F; Petrassi M; Alessandri C; Di Cristofano C; Della Rocca C; Gallo P
Eur Rev Med Pharmacol Sci; 2009; 13(6):431-42. PubMed ID: 20085124
[TBL] [Abstract][Full Text] [Related]
13. [Effect of hepatocyte growth factor and transforming growth factor-β(1) on atrial fibroblasts fibrosis].
Zhang JC; Chen JQ; Xu CX; Chen L; Lin YZ; Wu GS
Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Oct; 40(10):834-9. PubMed ID: 23302670
[TBL] [Abstract][Full Text] [Related]
14. Galectin-3 Induces Atrial Fibrosis by Activating the TGF-β1/Smad Pathway in Patients with Atrial Fibrillation.
Xiao M; Zhang M; Bie M; Wang X; Guo J; Xiao H
Cardiology; 2020; 145(7):446-455. PubMed ID: 32516780
[TBL] [Abstract][Full Text] [Related]
15. Increased TRPM6 expression in atrial fibrillation patients contribute to atrial fibrosis.
Zhang YJ; Ma N; Su F; Liu H; Mei J
Exp Mol Pathol; 2015 Jun; 98(3):486-90. PubMed ID: 25796343
[TBL] [Abstract][Full Text] [Related]
16. Atrial fibrosis and atrial fibrillation: the role of the TGF-β1 signaling pathway.
Gramley F; Lorenzen J; Koellensperger E; Kettering K; Weiss C; Munzel T
Int J Cardiol; 2010 Sep; 143(3):405-13. PubMed ID: 19394095
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of Late Gadolinium Enhancement - Magnetic Resonance Imaging in the Measurement of Left Atrial Substrate Remodeling in Patients With Rheumatic Mitral Valve Disease and Persistent Atrial Fibrillation.
Zhu D; Wu Z; van der Geest RJ; Luo Y; Sun J; Jiang J; Chen Y
Int Heart J; 2015; 56(5):505-10. PubMed ID: 26370371
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II activates signal transducers and activators of transcription 3 via Rac1 in the atrial tissue in permanent atrial fibrillation patients with rheumatic heart disease.
Xue XD; Huang JH; Wang HS
Cell Biochem Biophys; 2015 Jan; 71(1):205-13. PubMed ID: 25151145
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor-21 is positively associated with atrial fibrosis in atrial fibrillation patients with rheumatic heart disease.
Wang R; Yi X; Li X; Jiang X
Int J Clin Exp Pathol; 2015; 8(11):14901-8. PubMed ID: 26823820
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-β-mediated CD44/STAT3 signaling contributes to the development of atrial fibrosis and fibrillation.
Chang SH; Yeh YH; Lee JL; Hsu YJ; Kuo CT; Chen WJ
Basic Res Cardiol; 2017 Sep; 112(5):58. PubMed ID: 28871329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
